167 related articles for article (PubMed ID: 26365441)
21. A randomized study comparing different doses of superparamagnetic iron oxide tracer for sentinel lymph node biopsy in breast cancer: The SUNRISE study.
Rubio IT; Rodriguez-Revuelto R; Espinosa-Bravo M; Siso C; Rivero J; Esgueva A
Eur J Surg Oncol; 2020 Dec; 46(12):2195-2201. PubMed ID: 32631710
[TBL] [Abstract][Full Text] [Related]
22. Comparative Analysis of Postoperative Complications of Sentinel Node Identification Using the SentiMag
Lorek A; Steinhof-Radwańska K; Zarębski W; Lorek J; Stojčev Z; Zych J; Syrkiewicz A; Niemiec P; Szyluk K
Curr Oncol; 2022 Apr; 29(5):2887-2894. PubMed ID: 35621625
[TBL] [Abstract][Full Text] [Related]
23. Clinical significance of the lymphoscintigraphy in the evaluation of non-axillary sentinel lymph node localization in breast cancer.
Gherghe M; Bordea C; Blidaru A
Chirurgia (Bucur); 2015; 110(1):26-32. PubMed ID: 25800312
[TBL] [Abstract][Full Text] [Related]
24. Sentinel lymph node biopsy in patients with multifocal breast cancer.
Goyal A; Newcombe RG; Mansel RE; Chetty U; Ell P; Fallowfield L; Kissin M; Sibbering M;
Eur J Surg Oncol; 2004 Jun; 30(5):475-9. PubMed ID: 15135472
[TBL] [Abstract][Full Text] [Related]
25. Introducing SentiMag in a rural setting: a 5-year experience.
Sreedhar S; Maloney J; Hudson S
ANZ J Surg; 2021 Nov; 91(11):2404-2410. PubMed ID: 34309147
[TBL] [Abstract][Full Text] [Related]
26. [Preliminary study on a new sentinel lymphoscintigraphy agent 99mTc-Rituximab for breast patient].
Wang XJ; Lin BH; Yang Z; Ouyang T; Li JF; Xu B; Zhang Y; Zhang MY
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):200-3. PubMed ID: 16875605
[TBL] [Abstract][Full Text] [Related]
27. Magnetic resonance lymphography of sentinel lymph nodes in patients with breast cancer using superparamagnetic iron oxide: a feasibility study.
Shiozawa M; Kobayashi S; Sato Y; Maeshima H; Hozumi Y; Lefor AT; Kurihara K; Sata N; Yasuda Y
Breast Cancer; 2014 Jul; 21(4):394-401. PubMed ID: 22926506
[TBL] [Abstract][Full Text] [Related]
28. Evolution of sentinel lymph node biopsy for breast cancer patients in a rural setting: 10 years' experience.
Lau AWK; Lau VL; Sakowska MM
N Z Med J; 2023 May; 136(1575):42-49. PubMed ID: 37167939
[TBL] [Abstract][Full Text] [Related]
29. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase.
Goyal A; Newcombe RG; Chhabra A; Mansel RE;
Breast Cancer Res Treat; 2006 Sep; 99(2):203-8. PubMed ID: 16541308
[TBL] [Abstract][Full Text] [Related]
30. [Incidence of axillary recurrence after a negative sentinel lymph node result in early stages of breast cancer: a 5-year follow-up].
Ruano Pérez R; Ramos Boyero M; García-Talavera Fernández JR; Ramos Grande T; González-Orús JM; Gómez-Caminero López F; García Macias MC; Martín de Arriba A
Rev Esp Med Nucl Imagen Mol; 2012; 31(4):173-7. PubMed ID: 23067685
[TBL] [Abstract][Full Text] [Related]
31. Sentinel lymph node biopsy in a resourcelimited setting: a retrospective comparison of sentinel lymph node biopsy before and after the introduction of Sentimag at an academic breast unit.
Yousef M; Roodt L; Masu A; Nel D; Malherbe F
S Afr J Surg; 2023 Jun; 61(2):91-95. PubMed ID: 37381806
[TBL] [Abstract][Full Text] [Related]
32. Superparamagnetic iron oxide: a novel tracer for sentinel lymph node detection in vulvar cancer.
Jedryka MA; Klimczak P; Kryszpin M; Matkowski R
Int J Gynecol Cancer; 2020 Sep; 30(9):1280-1284. PubMed ID: 32675253
[TBL] [Abstract][Full Text] [Related]
33. Sentinel lymph node identification with radiopharmaceuticals in patients with breast cancer: a comparison of 99mTc-tin colloid and 99mTc-phytate efficiency.
Seok JW; Choi YS; Chong S; Kwon GY; Chung YJ; Kim BG; Park SJ
Breast Cancer Res Treat; 2010 Jul; 122(2):453-7. PubMed ID: 20532977
[TBL] [Abstract][Full Text] [Related]
34. Sentimag® Technique for Sentinel Lymph Node Biopsy in Breast Cancer Patients: Evaluation of Effectiveness, Feasibility and Challenges.
Nadeem M; Ansari B; Osborne C
Chirurgia (Bucur); 2022 Feb; 117(1):37-44. PubMed ID: 35272753
[TBL] [Abstract][Full Text] [Related]
35. Factors affecting sentinel lymph node detection failure in breast cancer patients using intradermal injection of the tracer.
Abdollahi A; Jangjoo A; Dabbagh Kakhki VR; Rasoul Zakavi S; Memar B; Naser Forghani M; Mehrabibahar M; Sadeghi R
Rev Esp Med Nucl; 2010; 29(2):73-7. PubMed ID: 19931946
[TBL] [Abstract][Full Text] [Related]
36. Blue dye versus combined blue dye-radioactive tracer technique in detection of sentinel lymph node in breast cancer.
Radovanovic Z; Golubovic A; Plzak A; Stojiljkovic B; Radovanovic D
Eur J Surg Oncol; 2004 Nov; 30(9):913-7. PubMed ID: 15498633
[TBL] [Abstract][Full Text] [Related]
37. High-resolution MR lymphography using ultrasmall superparamagnetic iron oxide (USPIO) in the evaluation of axillary lymph nodes in patients with early stage breast cancer: preliminary results.
Kimura K; Tanigawa N; Matsuki M; Nohara T; Iwamoto M; Sumiyoshi K; Tanaka S; Takahashi Y; Narumi Y
Breast Cancer; 2010 Oct; 17(4):241-6. PubMed ID: 19575282
[TBL] [Abstract][Full Text] [Related]
38. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer.
Kumar R; Jana S; Heiba SI; Dakhel M; Axelrod D; Siegel B; Bernik S; Mills C; Wallack M; Abdel-Dayem HM
J Nucl Med; 2003 Jan; 44(1):7-10. PubMed ID: 12515869
[TBL] [Abstract][Full Text] [Related]
39. The use of periareolar intradermal Tc-99m tin colloid and peritumoral intraparenchymal isosulfan blue dye injections for determination of the sentinel lymph node.
Argon AM; Duygun U; Acar E; Daglioz G; Yenjay L; Zekioglu O; Kapkac M
Clin Nucl Med; 2006 Dec; 31(12):795-800. PubMed ID: 17117076
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
